Mediclinic International Plc (MDC):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mediclinic International Plc (MDC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7941
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mediclinic International Plc (Mediclinic), formerly Al Noor Hospitals Group Plc is a healthcare service provider. The center offers services such as specialist-orientated, acute-care and multi disciplinary healthcare services. It also provides clinical services such as pre hospital emergency services, outpatient consultancy, hospital based emergency centres, highly specialised services, acute care inpatient services, nuclear medicine, radiology, laboratory and day case surgery. The center consists of 75 hospitals and 28 clinical which include more than 10600 inpatient beds and 410 operation theatres. It operates through its hospitals and clinics in Switzerland, Namibia, South Africa, and the UAE. Mediclinic is headquartered in London, the UK.

Mediclinic International Plc (MDC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mediclinic International Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Al Noor Hospitals Completes Acquisition Of Gulf International Cancer Centre For US$27 Million 10
Equity Offering 11
Al Noor Medical Completes IPO For US$344 Million 11
Acquisition 13
Ithmar Capital Sells 7.3% Stake in Al Noor Hospitals for USD142 Million 13
Mediclinic International Plc – Key Competitors 14
Mediclinic International Plc – Key Employees 15
Mediclinic International Plc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
May 24, 2018: Mediclinic International – 2018 Full Year Results And Proposed Final Cash Dividend 17
Nov 16, 2017: Mediclinic International – 2017/18 Interim Results And Declaration Of Interim Cash Dividend 29
May 24, 2017: Mediclinic International-2017 Full Year Results and Proposed Final Cash Dividend 37
Corporate Communications 38
Jul 25, 2018: Mediclinic International: Appointment of Dr Anja Oswald as an Independent Non-Executive Director 38
Mar 29, 2018: Mediclinic International: Chief Executive Officer succession and other changes to the composition of the Board and its Committees 39
Nov 27, 2017: Mediclinic International: Appointment Of Group Chief Executive Officer 40
Jul 25, 2017: Mediclinic CEO Announces Planned Retirement 41
Jul 25, 2017: Mediclinic International: Mediclinic CEO Announces Planned Retirement 42
Feb 22, 2017: Mediclinic International: Directorate Change 43
Legal and Regulatory 44
Apr 10, 2017: Mediclinic International: Swiss regulatory update 44
Other Significant Developments 45
Oct 17, 2018: Mediclinic International – Interim trading update 45
Apr 18, 2018: Mediclinic International: 2018 Full Year Trading Update 47
Apr 13, 2017: Mediclinic International: Full Year 2017 Trading Update 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Mediclinic International Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mediclinic International Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mediclinic International Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Al Noor Hospitals Completes Acquisition Of Gulf International Cancer Centre For US$27 Million 10
Al Noor Medical Completes IPO For US$344 Million 11
Ithmar Capital Sells 7.3% Stake in Al Noor Hospitals for USD142 Million 13
Mediclinic International Plc, Key Competitors 14
Mediclinic International Plc, Key Employees 15
Mediclinic International Plc, Other Locations 16
Mediclinic International Plc, Subsidiaries 16

List of Figures
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mediclinic International Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Mediclinic International Plc (MDC):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SK Innovation Co., Ltd.:企業のM&A・事業提携・投資動向
    SK Innovation Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SK Innovation Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Avivagen Inc (VIV):企業の財務・戦略的SWOT分析
    Summary Avivagen Inc (Avivagen), formerly Chemaphor Inc is a biotechnology company that provides drug development and animal healthcare products. The company develops science-based, natural health products for animals. It operates through divisions including companion animal health, food animal heal …
  • G Adventures Inc:企業の戦略・SWOT・財務情報
    G Adventures Inc - Strategy, SWOT and Corporate Finance Report Summary G Adventures Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Asklepios BioPharmaceutical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Asklepios Biopharmaceutical Inc (Asklepios Biopharmaceutical) is a drug development company that develops and markets novel protein and cellular based therapies. The company’s products include BNP-CHF, biostrophin, AskBio009, BNP-FVIII, BNP-RP, BNP-TLE, and BNP-OA. It also provides products …
  • Boone Electric Cooperative:企業の戦略的SWOT分析
    Boone Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Verastem Inc (VSTM):製薬・医療:M&Aディール及び事業提携情報
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • Novartis AG (NOVN):企業の財務・戦略的SWOT分析
    Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • EVN AG:発電所・企業SWOT分析
    EVN AG - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives) …
  • Icagen Inc:企業の戦略的SWOT分析
    Icagen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • SIGVARIS Management AG:企業の戦略的SWOT分析
    SIGVARIS Management AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Oriental Hotels Ltd:戦略・SWOT・企業財務分析
    Oriental Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Oriental Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Brooks MacDonald Group PLC (BRK):企業の財務・戦略的SWOT分析
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Eagle Cement Corporation (EAGLE):企業の財務・戦略的SWOT分析
    Eagle Cement Corporation (EAGLE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Coloplast AS (COLO B):企業の財務・戦略的SWOT分析
    Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • U.S. Army Institute of Surgical Research:製薬・医療:M&Aディール及び事業提携情報
    Summary U.S. Army Institute of Surgical Research (USAISR), a subsidiary of U.S. Army, is a medical research center that offers solutions for burn, trauma, and combat casualty care from time of injury to rehabilitation. The center conducts research in the areas of dental and trauma research detachmen …
  • Navigator Holdings Ltd (NVGS):石油・ガス:M&Aディール及び事業提携情報
    Summary Navigator Holdings Ltd (Navigator) is an oil and gas company that offers seaborne transportation of liquefied gases. The company transports ammonia, ethane, ethylene, ambient LPG, petrochemicals and LPG products. It provides fleet management, ship management, gas transportation and consultan …
  • Power Assets Holdings Ltd (6):電力:M&Aディール及び事業提携情報
    Summary Power Assets Holdings Limited (Power Assets) a subsidiary of CK Infrastructure Holdings Limited, is an investment holding company. The company through its subsidiaries, joint ventures, and affiliates, invests in power and utility-related businesses. The company has interests in electricity g …
  • Wanhua Chemical Group Co Ltd (600309):企業の財務・戦略的SWOT分析
    Wanhua Chemical Group Co Ltd (600309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Alzheimer’s Drug Discovery Foundation-製薬・医療分野:企業M&A・提携分析
    Summary Alzheimer's Drug Discovery Foundation (ADDF), formerly Institute for the Study of Aging is a drug discovery foundation that offers funds for drug discovery and development research programs in the field of Alzheimer’s disease, related dementias and cognitive aging. The foundation offers serv …
  • Hilton Worldwide Holdings Inc:企業の戦略・SWOT・財務情報
    Hilton Worldwide Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Hilton Worldwide Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆